Cell Therapy

Inside the microscopic battlefield of a human tumor, the difference between a patient’s recovery and a lethal progression often hinges on the metabolic stamina of a single type of immune cell. In the high-stakes battle against malignancy, the CD8+ T cell acts as the body’s elite soldier, but even

Ivan Kairatov is a leading figure in the biopharmaceutical landscape, recognized for his extensive contributions to the research and development of implantable medical technologies. With a career spanning the intersection of materials science and biotechnology, he has dedicated his expertise to

The persistence of T cells within the immunosuppressive environment of a solid tumor remains one of the most significant hurdles in modern oncology, as these cells frequently enter a state of terminal exhaustion that renders them incapable of mounting a sustained attack. This phenomenon is not

The medical landscape for rare genetic disorders is undergoing a profound transformation as advanced biotechnologies move from experimental stages to life-changing clinical realities for pediatric patients. For a five-year-old boy born with aromatic L-amino acid decarboxylase (AADC) deficiency, a

The diagnosis of B-cell acute lymphoblastic leukemia often strikes families like a sudden, life-altering storm, transforming a normal childhood into a grueling cycle of hospital stays, invasive procedures, and toxic chemical regimens. For decades, the medical community relied almost exclusively on

For decades, the fundamental understanding of the human immune system relied on a strict division of labor where specific molecules directed the activities of specialized cellular defenders against pathogens and tumors. This biological framework, often referred to as the MHC dichotomy, suggested